HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

desferrioxamine B-succinyl-phenylalanine(1)-octreotide

can be labeled with gallium (67) or (68); for in vivo targeting of somatostatin receptor-positive tumors; structure given in first source
Also Known As:
DFO-SMS; SDZ 216-927; SDZ-216-927; gallium (67)-DFO-SMS; gallium (68)-DFO-SMS
Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1. Neoplasms (Cancer)